Protective effect of prostaglandin E1 against ischemia/reperfusion- induced fiver injury: Results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy

Journal of Hepatology

Volumn 29, Issue 6, 1998, Pages 969-976

  Sugawara, Yasuhiko ^a   Kubota, Keiichi ^a   Ogura, Tsutomu ^b   Esumi, Hiroyasu ^b   Inoue, Kazuto ^a   Takayama, Tadatoshi ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

Author keywords

Inducible nitric oxide synthase; Interleukin 6; Prostanoid

Indexed keywords

AMINOTRANSFERASE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NITRATE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E1; PROSTAVASIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER PROTECTION; MALE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

EID: 0032404147     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80125-6     Document Type: Article

References (41)

1. 1. Hanazaki K, Kuroda T, Kajikawa S, Shinohara E, Haba Y, Iida F. Prostaglandin E1 protects liver from ischemic damage. J Surg Res 1994; 57: 380-4.
2. 2. Egashira T, Kim YI, Takayama F, Kudo Y, Yamanaka Y. Lipo-PGE1, prostaglandin E1 incorporated in lipid microspheres, protects injury of the liver caused by warm ischemia reperfusion. Free Radical Bio Med 1996; 21: 353-6.
3. 3. Ueda Y, Matsuo K, Kamei T, Ono H, Kayashima K, Tobimatsu M, et al. Prostaglandin E1 but not E2 is cytoprotective of energy metabolism and reticuloendothelial function in the ischemic canine liver. Transplant Proc 1987; 19: 1329-30.
4. 4. Arai Y, Asanuma Y, Nanjo H, Sato T, Kato Y, Omokawa S, et al. Experimental study on the effect of prostaglandin E1 on decreased hepatic tissue blood flow during operation. Jpn J Gastroenterol Surg 1992; 25: 782-5 (in Japanese with an English abstract).
5. 5. Lim SP, Andrews FJ, Christophi C, O'Brien PE. Misoprostol hepatoprotection against ischemia-reperfusion-induced liver injury in the rat. Dig Dis Sci 1992; 37: 1275-81.
6. 6. Nakadaira K, Tsukada K, Sakaguchi T, Shirai Y, Kurosaki I, Ohtake M, et al. A pharmacological analysis of prostaglandin E1 on portal blood flow after partial hepatectomy in rats. Surg Today 1993; 23: 277-9.
7. 7. Beck PL, McKnight GW, Kelly JK, Wallace JL, Lee SS. Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats. Gastroenterology 1993; 105: 1483-9.
8. 8. Schror K, Hecker G. Potent inhibition of superoxide anion generation by PGE1 and the PGE1 analogue OP-1206 in human PMN's-unrelated to its antiplatelet PGI2-like activity. Vasa (suppl) 1987; 17: 11-6.
9. 9. Haynes DR, Whitehouse MW, Vernon-Roberts B. The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology 1992; 76: 251-7.
10. 10. Sugawara Y, Kubota K, Ogura T, Esumi H, Inoue K, Takayama T, et al. Increased nitric oxide production in the liver in the perioperative period of partial hepatectomy under Pringle's maneuver. J Hepatol 1998; 28: 212-20.
11. 11. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg 1995; 169: 589-94.
12. 12. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161: 346-50.
13. 13. Gionchetti P, Vaira D, Campieri M, Holton J, Menegatti M, Belluzzi A, et al. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am J Gastroenterol 1994; 89: 883-7.
14. 15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-8.
15. 15. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977; 83: 346-56.
16. 16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
17. 17. Leal-Berumen I, O'Byrne P, Gupta A, Richards CD, Marshall JS. Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. J Immunol 1995; 154: 4759-67.
18. 18. Martin CA, Dorf ME. Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines. Cell Immunol 1991; 135: 245-8.
19. 19. Hirano T. Interleukin-6. In: Thomson AW, ed. The Cytokine Handbook, 2nd ed. London: Academic Press; 1994. p. 145-68.
20. 20. Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103: 1928-49.
21. 21. Sawada T, Falk LA, Rao P, Murphy WJ, Pluznik DH. IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter. J Immunol 1997; 158: 5267-76.
22. 22. Ma T, Zhu X. Interleukin-6 increases the levels of cyclic GMP and nitrite in rat hippocampal slices. Eur J Pharmacol 1997; 321: 343-7.
23. 23. Tatro JB, Romero LI, Beasley D, Steere AC, Reichlin S. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J Infect Dis 1994; 169: 1014-22.
24. 24. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 1991; 88: 9292-6.
25. 25. Shito M, Wakabayashi G, Ueda M, Shimazu M, Shirasugi N, Endo M, et al. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 1997; 63: 143-8.
26. 26. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1990; 212: 694-700.
27. 27. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor-alfa in the pathophysiologic alternations after hepatic ischemia/ reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-43.
28. 28. Chouaib S, Branellec D, Buurman WA. More insights into the complex physiology of TNF. Immunol Today 1991; 12: 141-2.
29. 29. Clavien P-A, Camargo CA Jr., Gorczynski R, Washington MK, Levy GA, Langer B, et al. Acute reactant cytokines and neutrophil adhesion after warm ishemia in cirrhotic and noncirrhotic human livers. Hepatology 1996; 23: 1456-63.
30. 30. Awad JA, Soteriou MC, Drougas JG, Stokes KA, Roberts II LJ, Pinson CW. Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in human and swine. Transplantation 1996; 61: 1624-9.
31. 31. Carlson LA, Ekelund L-G, Orö L. Circulatory and respiratory effects of different doses of prostaglandin E1 in man. Acta Physiol Scand 1969; 75: 161-9.
32. 32. Niki M, Ikeda T, Boku E, Abe H, Ueda H, Kato S, et al. Study on the optimal intravenous dose of prostaglandin E1 (PGE1). J Nihon Univ Med Ass 1997; 56: 59-64 (in Japanese with an English abstract).
33. 33. Totsuka E, Sasaki M, Takahashi K, Toyoki Y, Seino K, Chiba S, et al. The effects of intraportal prostaglandin E1 administration on hepatic warm ischemia and reperfusion injury in dogs. Surg Today 1995; 25: 421-8.
34. 34. Kawachi S, Shimazu M, Wakabayashi G, Tanabe M, Shirasugi N, Kumamoto Y, et al. Efficacy of intraportal infusion of prostaglandin E1 to imporove the hepatic blood flow and graft viability in porcine liver transplantation. Transplantation 1997; 64: 205-9.
35. 35. Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Nakai S, et al. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 1987; 6: 2939-45.
36. 36. Bensi G, Raugei G, Palla E, Carinci V, Buonamassa DT, Melli M. Human interleukin-1 beta gene. Gene 1987; 52: 95-101.
37. 37. Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, van Arsdell JN, et al. Molecular cloning of the complementary DNA for human necrosis factor. Science 1985; 228: 149-54.
38. 38. Sims JE, Acres RB, Grubin CE, McMahan CJ, Wingnall JM, March CJ, et al. Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci USA 1989; 86: 8946-50.
39. 39. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 1991; 10: 2821-32.
40. 40. Hokari A, Zeniya M, Esumi H. Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172. J Biochem 1994; 116: 575-81.
41. 41. Ponte P, Ng S-Y, Engel J, Gunning P, Kedes L. Evolutionary conservation in the ultranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984; 12: 1687-96.